Astellas Pharma (YPH.F) Q2 2024 Earnings

25AprConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-0.11
-0.01
0.09
0.2

Details

Expected EPS
-0.01781731071388404
Actual EPS
-0.11446581372489516
Surprise EPS
-0.1
Surprise Percent
+542.44%

Description

Astellas Pharma (YPH.F) has reported earnings of -0.11446581372489516 per share for Q2 2024.

0 Comments

Share your thoughts